A quiet week, with one item that actually matters: Britain began taxing vaping liquid on 1 October and nicotine pouches pay nothing. Elsewhere, the UK consultation that could strip the design off pouch cans closed on 2 October, and the FDA said it intends to replace the rule under which every US-legal pouch was authorised.
Week of Monday 28 September to Sunday 4 October 2026. As always, nothing goes in this roundup without a primary document — the statute, the regulator’s own page, the filing. Stories that circulated this week without one are listed at the bottom, with what is missing from each.
The week at a glance
| Item | Date | Change | Primary source |
|---|---|---|---|
| UK Vaping Products Duty in force | 1 Oct 2026 | £2.20 per 10ml on vaping liquid. Pouches outside the charge | Finance Act 2026, Part 4; HMRC |
| UK packaging and display consultation closed | 2 Oct 2026 | Proposals to white-out pouch packaging and restrict flavour names; comment window shut | DHSC consultation |
| FDA signals PMTA rule replacement | 28 Sep 2026 | Intent only; reviews continue unchanged | FDA press announcement |
| FDA authorised pouch list | unchanged | Still 43 products, two companies; page content current 21 Aug 2026 | FDA |
| BAT Capital Markets Day | 29 Sep 2026 | Horizon 2030 plan. No Velo or Modern Oral figure disclosed | SEC Form 6-K |
| FDA registration form redesigned | 28 Sep 2026 | Industry paperwork; pouches named as a covered category | FDA CTP |
Britain started taxing vape liquid. Pouches pay nothing
Vaping Products Duty came into force on 1 October. Section 115 of the Finance Act 2026 provides that “An excise duty is charged on vaping products produced in, or imported into, the United Kingdom” at “a rate of £2.20 per 10 millilitres, rounded down to the nearest penny”, and HMRC confirmed the same day that “All vaping liquids manufactured in, or imported into, the UK from 1 October are now subject to excise duty”.
Pouches escape, and the reason is worth stating precisely because it is not an exemption anyone legislated. Section 116(1) defines a vaping product as “a liquid that— (a) contains nicotine and either or both of glycerine and a glycol, or (b) is intended to be vaporised by a vape, and is not a medicinal product or a tobacco product.” The charge reaches liquids. A pouch is not one. There is no pouch duty in the UK and nothing in this Act creates one.
The net position on a British shelf as of this week: cigarettes taxed, snus prohibited outright, vaping liquid at £2.20 per 10ml, pouches at nil. That gap sits twenty-five days ahead of 29 October, when pouches become age-restricted for the first time under the Tobacco and Vapes Act 2026 — so the category is about to be regulated at the till while remaining the only nicotine product in the country with no product-specific excise. One date not to merge with the others: the unstamped-dealing offences and sales ban in sections 130 and 131 commence on 1 April 2027.
The consultation that could change what a pouch can looks like closed on Friday
DHSC’s consultation on tobacco and vapes packaging, appearance and display closed at “11:59pm on 2 October 2026”. Nicotine pouches are expressly in scope — the document lists “nicotine pouches, nicotine gum, nicotine strips, nicotine pearls” as examples of nicotine products on the UK market, and covers “Only nicotine products that are not medicinally licensed”.
What is proposed, in the department’s own words: “the packaging for vaping and nicotine products should be white”; it “should not include imagery”; “all text on packaging, including any branding or brand names, should be in a standard colour, font and typeface”; packaging “should use uniform shapes”; and “manufacturers should not use materials that enhance a product’s appeal, such as: glossy plastics, holographic foils, tactile features.” On flavours, DHSC proposes restricting descriptors “to a single, recognised flavour name, like apple or strawberry”, and restricting names drawn from “confectionery and sweets (such as ‘Chocolate’, ‘Candy’ and ‘Bubblegum’), desserts and cakes (such as ‘Brownie’ and ‘Cheesecake’), alcohol and other drinks (such as ‘Cola’).” The stated prompt: “Nearly 4% of teenagers report having tried nicotine pouches.”
These are proposals, not law, and the department has not published its response. But the window for anyone to argue with them shut this week.
FDA says it intends to replace the rule that authorised every US-legal pouch
On 28 September the FDA published a short press announcement stating that, “Based on FDA’s learned experience implementing the 2021 rule, the widespread development of an illicit and unregulated market, and the pace of new product introductions, FDA intends to evaluate changes to the PMTA regulatory framework, including through initiation of new rulemaking to replace the current framework.” It cites “a federal lawsuit filed in the U.S. District Court for the Northern District of Texas challenging the current regulatory framework.”
Read it carefully before getting excited. The announcement never uses the words “pouch” or “oral”, quotes no official, and sets no timeline. It is explicit that nothing changes now: “In the meantime, FDA will continue to process PMTA submissions, conduct premarket reviews, and issue regulatory decisions on new tobacco products.” What makes it relevant here is simply that every one of the 43 pouches a US consumer can lawfully buy was cleared under the 2021 rule the agency now says it intends to replace.
The negatives, which this week are the story
No new authorisation. The FDA’s authorised list still carries 43 products from Helix Innovations and Swedish Match USA, with the page’s content current date still reading 08/21/2026 — now roughly seven weeks stale. FDA’s standing wording is unchanged: these “are the only nicotine pouch products that may be lawfully sold in the United States”, and authorisation “does not mean these products are safe, nor are they ‘FDA approved.'”
Nothing in the Federal Register. A date-bounded search for “nicotine” across 28 September to 4 October returns a count of zero. Widen it to the whole quarter and the picture barely changes: the Center for Tobacco Products published nothing to the Federal Register in it.
No new UK secondary legislation on nicotine in 2026 at all, and no commencement regulations or implementation guidance landed this week for the 29 October age-of-sale date.
And BAT held a Capital Markets Day without giving a pouch number. The company’s 6-K filed 29 September sets out a Horizon 2030 plan and says BAT “aims to reach 50 million adult consumers with its Smokeless Products by 2030 and for these products to deliver 50% of Group revenue by 2035”, reporting that “As of 30 June 2026, BAT’s Smokeless brands were used by 35.0 million adult consumers worldwide” and that “Smokeless Products accounted for 19.8% of Group revenue.” Velo is named once, in a list. There is no Velo-specific or Modern Oral-specific volume, revenue or share figure anywhere in the release — pouches are folded into an aggregate alongside vapour and heated tobacco. For anyone trying to size the category from company disclosure, that absence is the finding.
One housekeeping item: on 28 September FDA launched a redesigned establishment registration and product listing form, naming “oral nicotine products, such as nicotine pouches” among the covered categories, with the annual registration deadline falling on 31 December. Industry paperwork, but a dated confirmation of how the category is classified.
Circulated this week, with no primary document
A nicotine pouch patent reportedly given up at the European Patent Office. Trade coverage on 30 September reported that Philip Morris relinquished a fast-release pouch patent in the face of a BAT challenge, naming EP 4 000 424. I cannot print that number. The EPO’s own publication record for EP 4 000 424 shows the applicant as a Danish company with no 2026 legal event and no opposition on file, while a different patent — EP 3 773 494 — carries an opposition by Nicoventures Trading Limited, a BAT subsidiary, on the EPO’s own record. One of those is the patent in the story and I cannot tell which from a primary source. Missing: the Board of Appeal decision itself and the register’s legal-event entry. The EPO register is robots-blocked and Espacenet returned 403.
Indian enforcement action against pouches. Reported this week, but every underlying event falls outside it — a health ministry letter of 19 September, an advisory board review of 27 August, a Bombay High Court ruling of 22 September. Missing: the letter or its circular number, the board’s minutes, and the judgment with a neutral citation. If it can ever be sourced it would make India a distinct regulatory model, treating pouches as unapproved drugs.
Canada’s health minister ruling out looser pouch rules. Reported 23 September, outside the window, and with no corresponding statement on any Health Canada page.
What to watch
The 29 October UK age-of-sale commencement is now twenty-five days away and no implementation instrument has appeared. The generational tobacco provisions are separately commenced on 1 January 2027; the two keep getting conflated and should not be. DHSC’s response to the packaging consultation is the next thing that would materially change what a pouch can looks like in Britain. And the FDA’s authorised list is the single page worth refreshing each week — seven weeks without movement is itself a data point.
Previous issues: 27 September and 20 September. The running position for every market is in the global regulation tracker and the global map.
Sources
- Finance Act 2026 (c. 11), Part 4 “Vaping products duty” — sections 115, 116 and 141.
- HM Revenue & Customs, “New Vaping Products Duty comes into effect”, 1 October 2026.
- Department of Health and Social Care, “Tobacco and vapes: packaging, appearance and display”, published 10 July 2026, last updated 7 September 2026, closed 2 October 2026.
- FDA, “FDA intends to evaluate changes to the PMTA regulatory framework”, 28 September 2026.
- FDA, “Nicotine Pouch Products Authorized by the FDA”, content current 21 August 2026, re-read 4 October 2026.
- British American Tobacco p.l.c., Form 6-K Exhibit 99.1, “BAT 2026 Capital Markets Day”, filed with the SEC 29 September 2026.
- Federal Register, date-bounded search for “nicotine”, 28 September to 4 October 2026: count 0.
Last verified 4 October 2026. Trade press was used to find leads only; no fact above rests on it.